EMA Suspends Some Activities To Focus On Brexit Relocation

The EMA has given some details of its business continuity plan for Brexit preparedness, which includes diverting some resources from lower-priority tasks to focus on core activities.

EMA offices
The EMA has drafted a business continuity plan for its Brexit-related relocation

The European Medicines Agency says that it is putting certain lower-priority activities on hold and may need to divert resources away from activities planned for 2018 so that it can prepare for its Brexit-related relocation and focus on its core tasks.

Keeping its operations running smoothly and retaining as many staff as possible during the move is a key priority for...

More from Approval Standards

More from Pathways & Standards

Generic Drug Office’s Policy Staff Returning To US FDA

 

The group had been laid off as part of the 1 April reduction-in-force, which led to missed guidance publication deadlines.

Nipah Vaccine With ‘Pandemic Potential’ Wins EMA PRIME Designation

 

The developers of the ChAdOx1 NipahB vaccine will be able to benefit from the early and enhanced support that the European Medicines Agency offers through its priority medicines scheme.

Elegy For SACHRP: US HHS Research Protection Panel Tackled Tough Pediatric Trial Questions

 

The termination of the HHS Secretary’s Committee on Human Research Protections closed an important forum for discussing pediatrics and pregnancy in clinical trial design, a former SACHRP chair said.